129 related articles for article (PubMed ID: 16188852)
1. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre.
Bernstrand C; Sandstedt B; Ahström L; Henter JI
Acta Paediatr; 2005 Aug; 94(8):1073-84. PubMed ID: 16188852
[TBL] [Abstract][Full Text] [Related]
2. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
[TBL] [Abstract][Full Text] [Related]
3. Late outcomes in children with Langerhans cell histiocytosis.
Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
[TBL] [Abstract][Full Text] [Related]
4. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
[TBL] [Abstract][Full Text] [Related]
5. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
6. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
[TBL] [Abstract][Full Text] [Related]
8. Nationwide Study of Factors Impacting Survival Outcome and Consequences in Children with Reactivation/Refractory Langerhans Cell Histiocytosis.
Monsereenusorn C; Suwannaying K; Buaboonnam J; Sathitsamitphong L; Techavichit P; Pakakasama S; Chainansamit SO; Anurathapan U; Komvilaisak P; Traivaree C; Sanpakit K; Charoenkwan P; Seksarn P
Asian Pac J Cancer Prev; 2024 May; 25(5):1831-1839. PubMed ID: 38809656
[TBL] [Abstract][Full Text] [Related]
9. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
10. Langerhans cell histiocytosis: 23 years' paediatric experience highlights severe long-term sequelae.
Martin A; Macmillan S; Murphy D; Carachi R
Scott Med J; 2014 Aug; 59(3):149-57. PubMed ID: 24996784
[TBL] [Abstract][Full Text] [Related]
11. Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.
Rigaud C; Barkaoui MA; Thomas C; Bertrand Y; Lambilliotte A; Miron J; Aladjidi N; Plat G; Jeziorski E; Galambrun C; Mansuy L; Lutz P; Deville A; Armari-Alla C; Reguerre Y; Fraitag S; Coulomb A; Gandemer V; Leboulanger N; Moshous D; Hoang-Xuan K; Tazi A; Heritier S; Emile JF; Donadieu J
Br J Haematol; 2016 Sep; 174(6):887-98. PubMed ID: 27273725
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of 131 children with multi-system Langerhans cell histiocytosis].
Wu FF; Gao YJ; Pan C; Chen J; Tang JY
Zhonghua Er Ke Za Zhi; 2016 May; 54(5):349-53. PubMed ID: 27143076
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis: 40 years' experience.
Maria Postini A; del Prever AB; Pagano M; Rivetti E; Berger M; Asaftei SD; Barat V; Andreacchio A; Fagioli F
J Pediatr Hematol Oncol; 2012 Jul; 34(5):353-8. PubMed ID: 22627580
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.
Barkaoui MA; Queheille E; Aladjidi N; Plat G; Jeziorski E; Moshous D; Lambilliotte A; Kebaili K; Pacquement H; Leverger G; Mansuy L; Entz-Werlé N; Bodet D; Schneider P; Pagnier A; Lutun A; Gillibert-Yvert M; Millot F; Toutain F; Reguerre Y; Thomas C; Tazi A; Emile JF; Donadieu J; Héritier S
Br J Haematol; 2020 Dec; 191(5):825-834. PubMed ID: 32700439
[TBL] [Abstract][Full Text] [Related]
15. Langerhans cell histiocytosis in neonates.
Minkov M; Prosch H; Steiner M; Grois N; Pötschger U; Kaatsch P; Janka-Schaub G; Gadner H
Pediatr Blood Cancer; 2005 Nov; 45(6):802-7. PubMed ID: 15770639
[TBL] [Abstract][Full Text] [Related]
16. Langerhans Cell Histiocytosis (LCH) in Egyptian Children: Does Reactivation Affect the Outcome?
Sedky MS; Rahman HA; Moussa E; Taha H; Raafat T; Hassanein O
Indian J Pediatr; 2016 Mar; 83(3):214-9. PubMed ID: 26133729
[TBL] [Abstract][Full Text] [Related]
17. Dynamic endocrine testing and magnetic resonance imaging in the long-term follow-up of childhood langerhans cell histiocytosis.
Maghnie M; Bossi G; Klersy C; Cosi G; Genovese E; Aricò M
J Clin Endocrinol Metab; 1998 Sep; 83(9):3089-94. PubMed ID: 9745408
[TBL] [Abstract][Full Text] [Related]
18. Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre.
Maia RC; de Rezende LM; Robaina M; Apa A; Klumb CE
Hematology; 2015 Mar; 20(2):83-92. PubMed ID: 24875166
[TBL] [Abstract][Full Text] [Related]
19. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
20. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]